Cell-surface products of the major histocompatibility complex (MHC) are thought to be the principal elements responsible for immune regulation and control of immune-mediated rejection of transplanted foreign tissue. Although much has been learned in recent years regarding the structure of MHC molecules and their role in antigen presentation, we still lack a complete understanding of subtle features of T-cell and peptide interactions with the MHC as well as the functional consequences of T-cell receptor (TcR) recognition of MHC molecules on different types of cells. The following single aim is based on the hypothesis that a relationship exists between the expression of certain T-cell immunoregulatory functions and the context in which a T-cell recognizes antigen in association with particular MHC molecules: We will continue to investigate the function, genetic restriction and antigen specificity of T-lymphocyte clones (TLCs) directed at influenza virus HA determinants but restricted by different interaction products encoded within the HLA-D subregions, HLA-DR, DQ and DP. These features will be examined using several different approaches: 1.Synthetic HA peptides will be used to probe the antigen specificities of TLCs. 2.The binding of radiolabeled peptides to DR, DQ and DP molecules will be investigated. 3.Peptide recognition will be examined using antigen presenting cells (APCs) transfected with normal class II genes and those encoding specifically altered molecules. 4.The specificities of TLCs will be correlated with sequence studies of their TcR genes. 5.The """"""""Ir gene"""""""" effects of influenza HA peptides will be studied in binding and functional assays. 6.Monoclonal antibodies (MoAbs) will be used to modulate specific TLC responses to explore the relationships among class II isotype-specific restriction, determinant selection and induction of functional subsets of T-cells. These approaches in addition to more classical ones developed in our laboratory will be used to address the following questions: 1.Do different D--subregion class II molecules restrict responses to different portions of the HA molecule? 2.Is there a correlation between the TcR sequence or T-cell function expressed and the antigenic determinant or MHC molecule recognized? 3.Can anti-class II monoclonal antibodies modulate responses to particular viral determinants at either the specificity or functional levels?

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Immunobiology Study Section (IMB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Bloodcenter of Wisconsin, Inc.
United States
Zip Code
Brady, M S; Lee, F; Eckels, D D et al. (2000) Restoration of alloreactivity of melanoma by transduction with B7.1. J Immunother 23:353-61
Brady, M S; Lee, F; Petrie, H et al. (2000) CD4(+) T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro. Cancer Immunol Immunother 48:621-6
Brady, M S; Eckels, D D; Lee, F et al. (1999) Cytokine production by CD4+ T-cells responding to antigen presentation by melanoma cells. Melanoma Res 9:173-80
Brady, M S; Eckels, D D; Ree, S Y et al. (1996) MHC class II-mediated antigen presentation by melanoma cells. J Immunother Emphasis Tumor Immunol 19:387-97
Ota, M; Geiger, M J; Rosen-Bronson, S et al. (1996) Diverse usage of human T-cell receptor gene segments in HLA-DR1 allospecific T-cell clones. Hum Immunol 49:122-9
Wu, S; Gorski, J; Eckels, D D et al. (1996) T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix pr J Immunol 156:3815-20
Kawaguchi, M; Eckels, D D (1995) Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells. Hum Immunol 43:136-48
Garlie, N K; Eckels, D D (1994) Idiotype-specific autologous T-cell interactions restricted by HLA-DR. Hum Immunol 39:69-75
Geiger, M J; Bull, M; Eckels, D D et al. (1993) Amplification of complementary DNA from mRNA with unknown 5' ends by one-way polymerase chain reaction. Methods Enzymol 218:321-35
Hurley, C K; Steiner, N; Wagner, A et al. (1993) Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation. J Immunol 150:1314-24

Showing the most recent 10 out of 26 publications